Gov. Ron DeSantis on Friday signed into law a bill expressly allowing a drug for child epilepsy patients that contains CBD, a ‘non-euphoric’ chemical from cannabis.
The Governor approved the measure (HB 7107) without comment. It applies to a drug known as Epidiolex, the “first FDA-approved drug that contains a purified substance derived from marijuana” and is used to treat seizures in children.
The bill, passed unanimously by both chambers this Session, specifically changes the drug’s classification in state law from a Schedule I substance to Schedule V.
The former means a “high potential for abuse, with no accepted medical use, and high potential for addiction,” while the latter means a “low potential for abuse, an accepted medical use, and a mild potential for addiction,” according to a staff analysis.
“Cannabis and compounds derived from cannabis are listed in Schedule I of both federal and Florida law,” it adds. Descheduling the medication “will prevent an interruption in the supply of the drug to Florida patients.”
Cannabidiol (CBD) and tetrahydrocannabinol (THC) are the major compounds in cannabis plants.
The ‘non-euphoric’ CBD is mostly extracted from hemp, a form of cannabis and botanical cousin to marijuana, and used for treating pain and relieving inflammation. THC is the psychoactive ingredient that causes marijuana’s “high.”
The bill follows a move last October by then-Attorney General Pam Bondi, who issued an emergency rule allowing the drug in Florida.
According to Bondi, as many as 4,000 Florida kids could use the drug. It’s used to treat seizures associated with Lennox-Gastaut syndrome, and Dravet syndrome, severe forms of epilepsy that begin in early childhood.
Bondi had used her authority “to schedule 133 chemical compounds commonly used in deadly synthetic drugs,” according to her spokesman, Whitney Ray. Her move on Epidiolex, he said last year, marked the “the first time she has used her authority to deschedule a drug.”
The bill took effect upon DeSantis’ signature.